Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
Xuying TanYan LiuJingan LongSi ChenGongcheng LiaoShangling WuChunlei LiLijun WangWenhua LingHui-Lian ZhuPublished in: Molecular nutrition & food research (2019)
TMAO aggravates liver steatosis by suppressing BA-mediated hepatic FXR signaling.